Montemore LT-Antagonist
Montelukast sodium, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor, which is widely used for the prophylaxis and chronic treatment of asthma.
![Montemore](http://moringapharmaceuticals.com/wp-content/uploads/2019/01/Montemore-10mg.jpg)
Montemore Montelukast as sodium 10mg
-
Adults
Aged 15 years and older
Indication Dose Dose Asthma 10 mg Once daily in evening Symptomatic relief of seasonal allergic rhinitis 10 mg Once daily in evening Exercise-induced bronchoconstriction 10 mg At least 2 hours before exercise Seasonal allergic rhinitis (SAR) 10 mg Once daily in evening Paediatric
Aged 6 to 14 years
Indication Dose Dose Asthma 5 mg Once daily in evening Symptomatic relief of seasonal allergic rhinitis 5 mg Once daily in evening Exercise-induced bronchoconstriction 5 mg At least 2 hours before exercise Seasonal allergic rhinitis (SAR) 5 mg Once daily in evening -
Hypersensitivity to any component of montelukast.